# A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

> **NCT00083473** · PHASE2 · TERMINATED · sponsor: **Titan Pharmaceuticals** · enrollment: 28 (—)

## Conditions studied

- Leukemia, Lymphocytic, Chronic
- Lymphoma, Small Lymphocytic

## Interventions

- **DRUG:** Pivanex

## Key facts

- **NCT ID:** NCT00083473
- **Lead sponsor:** Titan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 28 (—)
- **Last updated:** 2005-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083473, "A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00083473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*